GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Total Equity

ALMS (Alumis) Total Equity : $260.10 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Alumis Total Equity?

Alumis's total equity for the quarter that ended in Dec. 2024 was $260.10 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Alumis Total Equity Historical Data

The historical data trend for Alumis's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alumis Total Equity Chart

Alumis Annual Data
Trend Dec22 Dec23 Dec24
Total Equity
-195.24 -339.26 260.10

Alumis Quarterly Data
Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Equity Get a 7-Day Free Trial Premium Member Only -339.26 -385.93 -438.76 348.39 260.10

Alumis Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Alumis's Total Equity for the fiscal year that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=340.992-80.889
=260.10

Alumis's Total Equity for the quarter that ended in Dec. 2024 is calculated as

Total Equity=Total Assets(Q: Dec. 2024 )-Total Liabilities(Q: Dec. 2024 )
=340.992-80.889
=260.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alumis Total Equity Related Terms

Thank you for viewing the detailed overview of Alumis's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Alumis Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Alumis Inc (NAS:ALMS) » Definitions » Total Equity
Comparable Companies
AMLX DMAC DSGN XOMA RZLT NMRA FHTX PRQR ITOS AARD VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
280 East Grand Avenue, South San Francisco, CA, USA, 94080
Website
https://www.alumis.com
Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies.